The Dendritic Cell market is a subset of the biotechnology industry that focuses on the development of treatments and therapies based on dendritic cells. Dendritic cells are a type of immune cell that play a key role in the body's immune response. They are responsible for recognizing and responding to foreign substances, such as viruses and bacteria, and initiating an immune response. As such, they are a promising target for the development of treatments for a variety of diseases.
The Dendritic Cell market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotechnology startups. These companies are focused on developing treatments and therapies based on dendritic cells, as well as researching new ways to use them in the treatment of diseases.
Some of the companies in the Dendritic Cell market include Novartis, Merck, Pfizer, Celgene, and Gilead Sciences. Additionally, there are a number of smaller biotechnology companies, such as Immunovant, Immunocore, and Adaptimmune, that are focused on developing treatments and therapies based on dendritic cells. Show Less Read more
